ESSA Pharma Inc. — Director's Dealing 2022

Nov 1, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ESSA Pharma Inc. (EPIX)
CIK: 0001633932
Period of Report: 2022-06-29

Reporting Person: ZWEIFACH SANFORD S (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-29	Stock Option (Right to Buy)	$3.60	A	22500	Acquired	2032-06-29	Common Shares (22500)	Direct

Footnotes

F1: 100% of the options vest after 12 months from the date of grant.